Mead Johnson Nutrition Company (MJN) has been under a strong bear grip, hence the stock is down -3.65% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 1.46% in the past 1 week. The stock has risen by 1.52% in the past week indicating that the buyers are active at lower levels, but the stock is down -2.66% in the past 4 weeks.
The stock has recorded a 20-day Moving Average of 0.95% and the 50-Day Moving Average is 1.16%. Mead Johnson Nutrition Company (NYSE:MJN): stock turned positive on Friday. Though the stock opened at $88.68, the bulls momentum made the stock top out at $89.51 level for the day. The stock recorded a low of $88.4 and closed the trading day at $88.95, in the green by 0.19%. The total traded volume for the day was 574,766. The stock had closed at $88.78 in the previous days trading.
The company Insiders own 0.5% of Mead Johnson Nutrition Company shares according to the proxy statements. Institutional Investors own 98.11% of Mead Johnson Nutrition Company shares. During last six month period, the net percent change held by insiders has seen a change of -70.81%. Also, In the latest statement by the brokerage house, CLSA upgrades its outlook on Mead Johnson Nutrition Company (NYSE:MJN). The current rating of the shares is Outperform, according to the research report released by the firm. Previously, the company had a rating of Underperform. The rating by the firm was issued on August 3, 2016.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, childrens nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas, childrens milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company operates through three segments: Asia, Latin America and North America/Europe. The Companys Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe.